What is the BMI of a 170 cm tall, 87.9 kg adult and what weight‑loss management should be recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

BMI Calculation and Weight Management Recommendation

This patient has a BMI of 30.4 kg/m², which classifies them as Class I obese, and they require active weight loss treatment through a comprehensive lifestyle intervention program combining caloric restriction, physical activity, and behavioral therapy. 1

BMI Classification

  • BMI = 87.9 kg ÷ (1.70 m)² = 30.4 kg/m², which falls into the obesity category (BMI ≥30 kg/m²) 1
  • This BMI level is associated with increased risk of cardiovascular disease, type 2 diabetes, hypertension, and mortality 1
  • Waist circumference should be measured to provide additional cardiometabolic risk stratification: >102 cm in men or >88 cm in women indicates elevated risk 1

Mandatory Initial Assessment

Before initiating treatment, the following must be evaluated 1:

  • Cardiovascular risk factors: Blood pressure, fasting lipid panel, fasting blood glucose to screen for hypertension, dyslipidemia, prediabetes, or diabetes 1
  • Weight history: Previous weight loss attempts, patterns of weight gain/loss, dietary habits, physical activity level, family history of obesity 1
  • Medications review: Identify any drugs that may contribute to weight gain and consider adjustments 2
  • Obesity-related comorbidities: Screen for sleep apnea, fatty liver disease, and other complications 1

Treatment Indication and Goals

  • Weight loss treatment is definitively indicated for all individuals with BMI ≥30 kg/m², regardless of the presence of additional risk factors 1
  • Target weight loss: 5-10% of initial body weight over 6 months (approximately 4.4-8.8 kg for this patient) 1, 3
  • This magnitude of weight loss produces clinically meaningful improvements: reduced triglycerides, blood glucose, HbA1c, blood pressure, and improved LDL-C and HDL-C 3

Dietary Intervention (Cornerstone of Treatment)

Create a daily energy deficit of 500-750 kcal through caloric restriction 3:

  • Prescribe 1,500-1,800 kcal/day for men or 1,200-1,500 kcal/day for women 1, 3
  • This caloric deficit should produce a weight loss of 0.5-1 kg per week 1, 2
  • Macronutrient composition: Total fat 25-35% of energy, saturated and trans fats <7%, with emphasis on vegetables, fruits, legumes, and whole grains 1
  • Structured meal plans with portion control or meal replacements are evidence-based options to improve adherence 3, 2
  • Eliminate sugary drinks and ultra-processed foods 2

Physical Activity Prescription

Prescribe at least 30 minutes of moderate-intensity endurance exercise five or more days per week, combined with strength training 1, 3:

  • Moderate-intensity activities include brisk walking, cycling, or swimming 1, 3
  • For individuals with BMI ≥30 kg/m², choose activities that do not burden the musculoskeletal system 1, 4
  • Reduce sedentary activities (television watching, computer use) 1
  • Physical activity is crucial for long-term weight maintenance, though dietary restriction is more effective for initial weight loss 2

Behavioral Therapy

A minimum of 14-16 intensive behavioral therapy sessions over 6 months is recommended 3, 2:

  • Focus on self-monitoring (food diaries, weight tracking), nutrition education, and cognitive restructuring 2
  • Behavioral therapy combined with diet and exercise can produce 5-10% weight loss 2
  • Maximum weight loss typically occurs between 6-12 months 2

Pharmacotherapy Consideration

If the patient fails to achieve 5-10% weight loss after 3-6 months of intensive lifestyle intervention, add FDA-approved weight-loss medication 1, 3, 2:

  • Pharmacotherapy is indicated as adjunct therapy for BMI ≥30 kg/m² (or BMI ≥27 kg/m² with weight-related complications) 1, 3
  • Continue medication only if the patient loses ≥5% of initial body weight in the first 3 months or ≥2 kg in the first 4 weeks 1, 3
  • GLP-1 receptor agonists (semaglutide, liraglutide) or other approved agents should be considered 2, 4
  • Orlistat (120 mg with each fat-containing meal, maximum 3 capsules daily) is an FDA-approved option that requires concurrent multivitamin supplementation at bedtime 5

Bariatric Surgery Threshold

  • Bariatric surgery is not yet indicated at BMI 30.4 kg/m² 1, 3
  • Surgery becomes a consideration only if BMI reaches ≥35 kg/m² with weight-related complications or ≥40 kg/m² after failed non-surgical interventions 1, 3

Multidisciplinary Care Structure

Obesity must be managed as a chronic disease by a multidisciplinary team 1, 3:

  • Primary physician or obesity specialist, dietician/nutritionist, exercise specialist or physiotherapist, and psychologist or behavioral therapist 3
  • Regular monitoring of anthropometric measurements at least every 3 months during active weight management 4

Critical Pitfalls to Avoid

  • Do not recommend weight maintenance or "avoid weight gain" advice—this patient requires active weight loss intervention, not maintenance 1
  • Do not delay treatment—intensive management of any identified cardiovascular risk factors should be instituted immediately, regardless of weight loss efforts 1
  • Do not prescribe very-low-calorie diets (<800 kcal/day) or very-low-fat diets (<15% energy from fat) without specialized supervision 1
  • Do not expect rapid weight loss—programs promoting slow, steady weight loss (0.5-1 kg per week) are more effective long-term than rapid weight loss approaches 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Class II Obesity in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Weight Reduction in Morbid Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Class IV Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.